Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune-promoting therapy for cytomegalovirus pneumonia after renal transplantation
ChiCTR-TRC-08000282Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes, IgG Antibodies → Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of immune globulin and human cytomegalovirus immune globulin in Cytomegalovirus pneumonia (2 arms), sponsored by Sun Yat-sen University. Primary endpoints: Average hospital days and Recovery rate of cytomegalovirus pneumonia. Started Jan 2009; status: completed.
02
Drugs
immune globulinhuman cytomegalovirus immune globulin
03
Conditions
Cytomegalovirus pneumonia
Beyond the preview
Go deeper on ChiCTR-TRC-08000282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000282.